Article

Susan Urba, MD, Discusses Treatments for CINV

Susan Urba, MD, Medical Director, Symptom Management & Supportive Care Program, University of Michigan, says that preventative medications given prior to treatment are necessary in order to improve the quality of life for patients with chemotherapy-induced nausea and vomiting (CINV).

Susan Urba, MD, Medical Director, Symptom Management & Supportive Care Program, University of Michigan, says that preventative medications given prior to treatment are necessary in order to improve the quality of life for patients with chemotherapy-induced nausea and vomiting (CINV).

Dr Urba says that vomiting is well controlled, but nausea is still a problem despite the preventative medication. "For now, prevention is the key," Dr Urba said. "Giving the adequate drugs for the category that the patient is in, and hopefully the patient's quality of life will improve."

Related Videos
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Douglas Flora, MD, FACCC
Molly Dean, MSW, Siftwell
Dr Xin Hu
Bridgette J. Picou, LVN, ACLPN, The Well Project
Priscilla Tsondai, MD, MPH, IAS/CIPHER
Mia Moore, PhD, Fred Hutch Cancer Center
rachel rohaidy
Steven Daniel Daveluy, MD, FAAD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo